Document is current
Any future updates will be listed below
-
Authors
Kolanukuduru, Kaushik P. https://orcid.org/0009-0001-9525-2600
Busby, Dallin
Grauer, Ralph
Choudhary, Manish K.
Mandel, Asher
Maheshwari, Ashutosh
Tewari, Ash K.
Menon, Mani
- License Information
-
More Information
Article History
Received: 15 March 2024
Accepted: 20 May 2024
First Online: 10 July 2024
Declarations
:
: This project fully considered and protected the right and interests of the study subjects. This study was approved by the institutional review board at the institution where the study took place - Icahn School of Medicine at Mount Sinai (IRB # 24–00275). IRB waived the need for ethics approval and informed consent as all data analysed were collected as part of routine diagnosis and care.
: Dr. Ash Tewari has served as a site-PI on pharma/industry sponsored clinical trials from Kite Pharma Inc., Lumicell Inc., Dendron Pharmaceuticals LLC, Oncovir Inc., Blue Earth Diagnostics Ltd., RhoVac ApS., Bayer HealthCare Pharmaceuticals Inc., Janssen Research and Development LLC. Dr. Tewari has served as an unpaid consultant to Roivant Biosciences and advisor to Proxamo. He owns equity in Promaxo.
